Location: | London |
---|---|
Salary: | £61,825 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 8th April 2025 |
---|---|
Closes: | 15th April 2025 |
Job Ref: | MED05165 |
Location: Hammersmith Campus
About the role
We are seeking to appoint a Clinical Research Fellow in Urology to participate in research projects that focuses on novel diagnostic tests and minimally invasive therapies for prostate cancer. The Imperial Prostate team led by Professor Hashim Ahmed and Mr Taimur Shah has an international reputation in this field with regular visitors from Europe and North America to learn research and clinical techniques proposing a change in the prostate cancer diagnosis and therapeutic pathway. We have a portfolio of 13 clinical trials that are either completed or ongoing.
What you would be doing
The successful candidate will be part of exciting ground-breaking research studies under the supervision of Prof. Hashim Ahmed (Chair of Urology) and Mr. Martin Connor (NIHR Academic Clinical Lecturer in Urology). These projects involve working within multi-disciplinary clinical and research groups such as imaging, pathology, engineering and molecular biology. The post will also involve liaising with Imperial’s Joint Research Office, industry, regulatory authorities and the Imperial Clinical Trials Unit – Surgery section.
During the course of the appointment the Clinical Research Fellow will be expected to undertake studies leading to a higher research degree (MD/PhD).
What we are looking for
The appointee’s research work must take place within the Department of Surgery and Cancer and Imperial Urology at Imperial College Healthcare NHS Trust, but they may work in collaboration with divisions other than Surgery. Clinical work will be undertaken to provide nominal on-going experience in clinics and theatres at the direction of Professor Ahmed and Mr Taimur Shah.
A degree in medicine (MBBS or equivalent) is essential, as is full General Medical Council registration. Experience of multi-disciplinary working is essential as is knowledge of surgery and urology.
What we can offer you
The successful candidate will be involved in delivery of the Prostate Cancer UK funded randomised controlled trial evaluating the role of PSMA PET/CT imaging in directing treatment in patients with high-risk prostate cancer, called IP13-AVIDITY.
Further information
This is a full time, fixed term for 3 years based at Hammersmith Campus.
As this post is exempt from the Rehabilitation of Offenders Act 1974, a satisfactory Disclosure and Barring Service (DBS) check, at the appropriate level, will be required for the successful candidate.
If you require any further details about the role, please contact:
Prof. Hashim Ahmed, hashim.ahmed@imperial.ac.uk and
Mr Martin Connor m.connor@imperial.ac.uk
Type / Role:
Subject Area(s):
Location(s):